News

Phil Walls Quoted in Risk & Insurance on Medical Marijuana


Medical marijuana use continues to be a topic of debate in the workers’ compensation space, with states reviewing its legality and industry professionals trying to better understand its utility as a treatment. Recently, myMatrixx Chief Clinical Officer, Phil Walls, was quoted in an article for Risk & Insurance Magazine covering this subject. In the wide-ranging …

Update to Search for Safe and Effective COVID-19 Vaccines Document


One of the top priorities for successfully mitigating COVID-19 is the development of an effective yet safe vaccine. Currently there are more than 100 potential vaccines in development, with projections for commercial availability a year or more away. To provide the latest information, myMatrixx is making regular updates to the “COVID-19 — Searching for Safe …

MedWatch Update on Hand Sanitizers


During June and July, the FDA has issued a series of warnings that some commercial hand sanitizers contain methanol and it has asked a number of manufacturers to recall their products. Also known as wood alcohol, methanol is intended for industrial use in products such as pesticides and solvents. It has no medical uses, and …

MedWatch Update on Naloxone


In a Safety Communication on July 23, 2020, the FDA alerted prescribers, pharmacies and patients of a new requirement for opioid drugs. It is directing drug companies that make opioids for pain relief and for use in treating opioid use disorder to add information on the labels about the use of naloxone. As emergency treatment …

Mike Cirillo and Phil Walls Quoted in Post for 2020 Virtual WCI Conference


myMatrixx President, Mike Cirillo, and Chief Clinical Officer, Phil Walls, were recently quoted in an article for the Workers’ Compensation Institute (WCI). Due to the COVID-19 pandemic, WCI will be holding its annual conference virtually this year and are highlighting the sponsors, including myMatrixx, in a series of posts. In the article, entitled “Clinical Vigilance …